Partner Insight: A renewed focus on 'knowledge-intensive' companies should help investors realise that these entrepreneurial companies are found in sectors other than biotech or technology.
The problem for any government hoping to legislate for investment in scale-up companies, as defined by the Patient Capital Review last year, is it inevitably leads to attempts at definitions which can...
All-day event on 24 April
Consequences could be more severe than in stress tests
AFH has six segregated mandate funds
Variable operating expenses